Cannabis consumption and psychosis or schizophrenia development
- PMID: 30442059
- DOI: 10.1177/0020764018801690
Cannabis consumption and psychosis or schizophrenia development
Abstract
Objective:: Cannabis consumption produces psychopathology, in some cases psychotic episodes, which are of our interest in this work. However, the relationship between cannabis use and psychosis has not been fully elucidated. The objectives of this work are to (1) review the current state of knowledge on the association of cannabis use with the risk of the development of psychosis or psychotic symptoms in people without schizophrenia and (2) assess the consistency of the hypothesis that cannabis use is associated with increased risk of psychosis in people without schizophrenia.
Method:: This work included research done in humans until May 2018 with the keywords 'cannabis' and 'psychosis', published in English and Spanish, in the PubMed database.
Results:: In all, 66 papers were analyzed, of which 23 were cohort trials and 43 were reviews.
Conclusion:: Cannabis use doubles the risk of developing psychosis in vulnerable people. There even exists a relationship regarding the dose used and the age of first use. Gene-environment interactions that modulate the association between cannabis use and the presence of psychosis have also been described.
Keywords: Cannabis; cohorts; psychosis; psychotic symptom; risk factor; schizophrenia.
Similar articles
-
Cannabis and psychosis: have we found the missing links?Asian J Psychiatr. 2013 Aug;6(4):281-7. doi: 10.1016/j.ajp.2013.03.012. Epub 2013 May 3. Asian J Psychiatr. 2013. PMID: 23810133 Review.
-
[Does the use of cannabis increase the risk for psychosis and the development of schizophrenia?].Laeknabladid. 2014 Sep;100(9):443-51. doi: 10.17992/lbl.2014.09.556. Laeknabladid. 2014. PMID: 25242813 Review. Icelandic.
-
[Behavioral, cognitive and psychophysiological effects of cannabinoids: relevance to psychosis and schizophrenia].Braz J Psychiatry. 2010 May;32 Suppl 1:S15-30. Braz J Psychiatry. 2010. PMID: 20512267 Review. Portuguese.
-
Cannabis and psychosis/schizophrenia: human studies.Eur Arch Psychiatry Clin Neurosci. 2009 Oct;259(7):413-31. doi: 10.1007/s00406-009-0024-2. Epub 2009 Jul 16. Eur Arch Psychiatry Clin Neurosci. 2009. PMID: 19609589 Free PMC article. Review.
-
Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases.Br J Psychiatry. 2005 Dec;187:510-5. doi: 10.1192/bjp.187.6.510. Br J Psychiatry. 2005. PMID: 16319402
Cited by
-
Perturbation of 3D nuclear architecture, epigenomic aging and dysregulation, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 2-Metabolome, immunome, synaptome.Front Psychiatry. 2023 Oct 3;14:1182536. doi: 10.3389/fpsyt.2023.1182536. eCollection 2023. Front Psychiatry. 2023. PMID: 37854446 Free PMC article. Review.
-
Cannabis use and psychotic disorders in diverse settings in the Global South: findings from INTREPID II.Psychol Med. 2023 Nov;53(15):7062-7069. doi: 10.1017/S0033291723000399. Epub 2023 Mar 23. Psychol Med. 2023. PMID: 36951137 Free PMC article.
-
Aberrant salience in cannabis-induced psychosis: a comparative study.Front Psychiatry. 2024 Jan 8;14:1343884. doi: 10.3389/fpsyt.2023.1343884. eCollection 2023. Front Psychiatry. 2024. PMID: 38260781 Free PMC article.
-
The history, evolution, and practice of cannabis and E-cigarette industries highlight necessary public health and public safety considerations.J Safety Res. 2023 Feb;84:192-203. doi: 10.1016/j.jsr.2022.10.019. Epub 2022 Nov 11. J Safety Res. 2023. PMID: 36868647 Free PMC article. No abstract available.
-
Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality.Int J Mol Sci. 2024 Jun 6;25(11):6268. doi: 10.3390/ijms25116268. Int J Mol Sci. 2024. PMID: 38892456 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical